Eton Pharmaceuticals (ETON) Change in Account Payables (2018 - 2025)

Eton Pharmaceuticals has disclosed Change in Account Payables across 8 years of filings, most recently posting -$3.3 million for Q4 2025.

• Change in Account Payables for Q4 2025 came in at -$3.3 million, down 321.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.8 million (up 193.7% YoY), and the FY2025 annual result was $6.8 million, up 193.7% from the prior year.
• Change in Account Payables came in at -$3.3 million for Q4 2025 at Eton Pharmaceuticals, down from $2.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.3 million in Q2 2025 to a low of -$3.3 million in Q4 2025.
• The 5-year median for Change in Account Payables is $11500.0 (2022), against an average of $430050.0.
• Across the five-year window, Change in Account Payables slumped 1033.09% in 2021 and surged 5688.46% in 2025, its largest moves.
• Eton Pharmaceuticals' Change in Account Payables stood at -$1.3 million in 2021, then surged by 156.11% to $712000.0 in 2022, then slumped by 85.25% to $105000.0 in 2023, then jumped by 1311.43% to $1.5 million in 2024, then sank by 321.59% to -$3.3 million in 2025.
• The last three Change in Account Payables figures came in at -$3.3 million (Q4 2025), $2.1 million (Q3 2025), and $7.3 million (Q2 2025), per Business Quant data.